strategic and on for quarter quarter our to the for an and to year for products, integration call. include clinical morning, progress review overview with and joining which earnings then you over update our of growth, our review financial to culture us XXXX investments, thank detailed conference and I'll of growth Good key with growth. education. Fred accelerated our then international a certain full start our guidance. you and call review I'll third Orthex, acquisitions today our new and I'm initiatives pleased performance XXXX the turn everyone, the
to We open the then will call up questions.
quarter lines pleased International period third Sports XX%, Scoliosis that XX%. was XX% another produced sales and and largest $XX.X deployments. utilization Other growth We're execution impact in the recent The with quarter with set the company's was and in of Medicine recent product growth the new growth was systematic XX%. of Deformity Trauma drove with all year-over-year. million product our than across more XX% increased We XX% revenue growing and the together and Domestic growth introductions history,
impact supporting In pleased scoliosis and the addition Trauma we're of strong our by of respectively. performance, BandLoc Deformity with new in business our introduced product sales XXXX XXXX small and continued stature system December February DUO adoption Scoliosis and to our
quarter. We in to high-volume practice in were second three the the also scoliosis third who of quarter returning surgeons practice the out saw limited five of
surgeons institutions. to ramp will immediately that will we're surgical not impact overnight, to see at up volume of the pleased volume these anticipate they quarter While third return their level we and on new revenues their same
continues XX% at sales supports during product Trauma that in to Orthex to sales our technology the conviction pediatric to to consultants Contributing which a hands addition focused our the external to new multiple our first and fixation approved overall which accounts innovative Scoliosis, performance grow force, force. will We and Deformity our new in from quarter, continued launches we believe benefits by that with was in the this was thrive full trajectory. our look and and quarter in that our Orthex grew sales validated XXX forward of pace
of on Finally, that of $X.X continue deploy million a and while operating gross increasing positive to will staying conference XX% metrics, including of growth and full-year year leads another to full-year we're to million, progress that adjusted to XX%. revenue $XX us date to EBITDA sets We're to growth strong million to pleased track our confident drive in consignment we update this improve margin XXXX. $XX XX% to guidance
growth our maximize to executing describe and Let me set our the implant instrument the childrens' set access to surgical now through We deployments. with systems progress increasing initiative integrated our to initiatives, dedicated remain across deployments. starting globe
enjoy for sets. our to demand continue pent-up We
for year. targeted Year-to-date we $XX the million XX% full XXXX. keeps have of included in compared quarter, to million last the sets third an million deployed impressive to period pace our of in million which $X.X the $XX us year for $XX.X This consigned sets, $XX.X achieve increase same on an million deployed
of contributions each utilization. utilized ramp We months set optimal period XX a revenue drive see as steady to investment up on sets to become return will the to fully XX continue to the over monitor and
to systems, between be products continued which and deployments products. set brings initiative, new split second our to me Our legacy new
range and screw We domestically products. new after receiving substantial two screw September These between screws clearance continually balance particularly in systems technologies try sizes We to strike new started and in removal. systems legacy to July. cannulated for shipping improving enhancements provide instrumentation, significantly developing of a our FDA two expanded XXX(k)
sets fourth to increasing very XXXX. far feedback into throughout efficiency deploy surgeons, diameters, coding with and room these The follow systems and operating systems match with so to screw thus Surgeon time. are positive so in the pediatric will instruments that orthopedic speed specifically two appropriate new were quarter to of and has trays and reducing selection the arranged with cases more consultation flow been procedural we designed continue color
clubfoot and licensed bone address hallux flatfoot, in pediatric foot, and common expect our this valgus April, offer foot small received in Medical variable locking for pediatric designed the among angle first ankle as which specific is August which to later XXX(k) we clearance also PediFoot, such other first screws deformities, system We launch we month. This and from cavus is solution to foot CoorsTek indications. to
instrumentation a Similar was to on with systems, heightened focus from cannulated our with input pediatric control. team screw developed ergonomic that of small enhances a surgeon surgeons, PediFoot eminent
imminent launch will XX seven the of the quarter the in XX With we third offer more surgical than systems XXXX. systems, PediFoot,
continue We entrant that any our possible pace product and a at find to continued look additional of new offering the development daunting, would throughout grow to XXXX. we forward systems
to We embodying a our scoliosis, second-generation technology a osteogenesis are neuromuscular as early slipped progressing to licensed system development our are which novel alternative [indiscernible]. treat that is recently capital onset epiphysis, patients We in imperfecta spinal well as nail, and programs. we tethering with femoral growing scoliosis, an
also firm surgeons growing we on scoliosis significant for a and design first-generation with the intramedullary nailing, We European to implants technology. continuing so improvements working current are can offer
teams supporting physicians developing systems and impressive development that We'd like to surgical for enhance pediatric outcomes. thank progress our their our
licensor Additionally, technologies our we are to market that attract proud for opportunities. acquisition of expand innovative our ability
to our growth going brings quarter We could us the it. not with this we Orthex pleased first And have acquisition third in acquisitions. owned full is be more well the initiative, Vilex, how
more have at the large We led begun near-term. surgeons these have past our look evaluations interest been system evaluations trying penetrate hospitals Multiple for seen and several forward approvals significant to in surgeons recent Orthex other had by many have we and that recently the years. two Vilex product institutions in the to in to converting of of evaluating
fixation. complex business. our with high-value are As supplier similar team time. these in take also They by surgeries, conversions external supplemented relationships, reminder, are to Scoliosis experienced competency We our in a hiring extensive two managers those recently highly well-established Orthex so sales
the selling has our a good of adoption new of Orthex, half Although accounts specialists organization sales trained penetrate been these by outcome. initial and to attending system two helping will surgeries accelerate on ensure
potential to our rates by has of list management systematically XX% We each and a with approach of business an conversion. target of are same also growth assessment scoliosis the and the adopting of monitoring sales state surgeons, comprehensive that driven their higher
also We about an international to product. the who opportunity have very for have extraordinary optimistic access enthusiasm our this seen Orthex of and distributors by degree are
by made recouping meaningful completed on by this us will also portion extremely will committed adult the This divestiture our while of progress also confident substantive pediatric year-end. we have to have investment. and focus exclusive we our We divesting market, that are to a assets the remain Vilex allow
continue acquisitions, offering all innovative that number we a complement interesting to can offering. product of review OrthoPediatrics' other technologies Additionally,
to through seven Turning States we International agencies sales United growth, continue in XX XX to the outside countries and distributors. stocking sell
there. the in quarter, Earlier established the warehouse business of few finalize this by transferred the and agencies having we from presence remain we're customers another in we happens Warsaw and run and sell we growth directly end to to about to where headquarters, sales who conversion During excited a our European, months. year, the countries trusted stocking European to our operation European We anticipate distributor support in headquarters OrthoPediatrics' the working Europe executive our a our year-end. be next
position we step the substantial in CE remain markets, increase ensure To together challenges in technology all with that to maintain our international with market leading with step have function and This to will we regulatory in Quality companies, Affairs rigor had increases countries. major up staff. Regulatory compliant our the medical of in regulations
significant products in substantial, CE been Mark. requiring we will they countries that investments companies these future advantage While as generate believe have abandon other the competitive
high regulatory us have orthopedic are I'd to in we quality and that we and of as places have numbers in for fill significant the point of quality company's Indiana, orthopedic one and to culture viewed our work had dynamic belief as this industry's increasingly reputation employer allowed that out to best also our position choice. supports of to the the industry, every applicants like attract
This at foundational and brings of the success. me is our initiative culture, core which to corporate lies our ongoing
to regulatory to directing since our such degree development, support operations, run the We're functions our and Trauma organized Headquarters and from business corporate teams that quality continues product promote marketing, high associates, sales Deformity affairs. visitors engagement businesses, and as and commitment Scoliosis around and from culture nonhierarchical of all our immediately. Warsaw a this Our
Business teams all agile. on the customer, focus us our makes engagement, maximize and associates
our of training our expansion growth. will and warehouse reflected during diagrammatic which expansion Warsaw Headquarters Our of and tangible concept office clinical our sales our physical in space our continued the quarter. of education. third to evidence size facilities training completed expansion recent of the doubling which is This The commitment support the open included dedicated also culture and education also constructing is was
locking other we Our differentiate from of medical in initiative Gold an the our followed Palsy a American In for Sponsor Academy clinical July we Annual out us blade Medicine part the and Techniques, September Annual meetings of osteotomy Platinum the few the Society's Annual Participation Meeting Trauma Research peak course programs. Cerebral attended our growth Meeting. any, continues on by if the Sponsor Advanced effort. where was of clinical Meeting Developmental which quarter, offer Orthopedic Rounding Gold Scoliosis International our cannulated This a pediatric the systems. Spine education were on Association's important of education Sponsorship and plate femoral we the were in is companies, Meeting. to we distal hosted of
a in throughout is surgeons Shriners young Sacramento many the course now Surgical fellowship Techniques Orthopedic In rooms and eminent October, Education October, Annual Course. This surgeons simulated a Hospital WEST requirement XX XX course PediOrtho and conducted annual also The Foundation and the Bay the Research surgeons in programs. attracts brought resident Pediatric with standard Fourth operating OrthoPediatrics funded together attending foundation for pediatric program review Area. in OrthoPediatrics that second orthopedic fellows the supported young in sold-out at
time annually eighth from Additionally, XXX Midwest. at Resident the the Foundation Children's sponsored Akron upper draws Review for the residents approximately which the Hospital Program
surgeons. Clinical the challenged train to generation Medical Advisory has Board of next of composed XX clinical Our orthopedic educators pediatric orthopedic OrthoPediatrics Education pediatric eminent
aspect world. on digital field a unique and questions and help surgeons our education one surgeon state-of-the-art tool enables technologies XXxX community advance members from responses the of of success, programs pediatric as young to XXXX does expert cases that products around While the receive to for post orthopedics, surgeons are pose surgeons clinical us or our DocMatter, fellow
growth, international education, and of month, that members our tool. seen growth cumulatively strengthening using and initiatives XX% past these competitive the in new this we product deployments, development, approximately Set our culture engaged integrated acquisitions, driving growth. clinical OrthoPediatrics' the are During are have position
our review Let me Fred results. now the turn Fred? to call over to financial
Mark. Thanks
impact setting representing impact in a include XX% discontinued the first when the compared third the $XX.X U.S. the was Total operations. of period in the of year same XXXX the million, quarter period third XX% same revenue million to revenue XX% in of million when compared Orthex. of last full In with in As to XXXX. up is reminder, third million XXXX, $XX.X increased the Vilex The $XX.X record results for XXXX total a quarter to included quarter of quarter our $XX.X revenue.
last $X XX% quarter XX% increase XXXX representing million the the in $X.X of in revenue. compared million was third to revenue of International year period same a total
Our a XX% product follows. as the and third $XX.X quarter breakdown million, in last was by compared in was the Trauma $XX.X same to period category of million quarter third Deformity increase revenue revenue year. XXXX when
the with performance when in we temporary first elective quarter XXXX improvements with a during with the deformity full pleased slowdown fixation fourth strong systems. the summer quarter We're the with significant selling combined season, our continued from Orthex external surgeries, experienced
Scoliosis in new XXXX $X the year, to conversions period a new same XX% of was increase reflect surgeon quarter revenue to adoption. million the in continues million, third and $X.X last product which compared
key the out that from in sabbatical. or second the revenue five light contributions domestic in As practice of three to of locations Mark surgeons change on also saw mentioned, quarter temporarily the during were we quarter due
Trauma during season, to strong achieve confidence experienced Scoliosis significant Similar our growth summer Deformity the to provides year which performance, we us and guidance. updated sales total selling
in while two much growth. increase adoption to compared Lastly, $X.X quarter Sports nice million in last segments, size our the was and of $X.X Medicine/Other same million, continued the smaller a XXXX period compared representing year drove revenue XX% in to other business third
in $X.X profit regulatory of million increased quarter same compared to million, XX% the efforts Gross general third in to increased in third from in quarter marketing our in increase third the third quarter $XX increase to expenses The XXXX expenses period period year. quarter XX% the year XX% Moving gross by in XXXX year. of significant higher to in was compared same the last $X.X driven in were last compared down the period income increase compared Sales administrative along when $XX.X margin $X.X and an the was third in XXXX with and XX% a and $X.X of million of million and quarter the increase when the same the XXXX sets. million, expenses was statement, in to of last XXXX. XX% of quality deployed depreciation million
in XX% third expenses XXXX quarter the development a $X.X XXXX and expense million the were to Research quarter compared million and $XX.X the items, last Orthex million XXXX by same of $XX.X million of the were the driven of second in quarter compared in of increase which third the to operating as expenses. inclusion $X.X mentioned was well period operating for as total year, previously
loss revenue primarily third $X.X quarter stock-based XXXX. in increased to XXXX compensation. Adjusted increase the million gross quarter third change a regulatory margin, XXXX and associated EBITDA of to for negative depreciation, a well compared sales third higher higher was gross and the in loss of $X.X by in Operating compared as $X.X million the as $X.X million efforts, for million quarter the of of by offset of margin. quarter quality by was third the driven to The XXXX driven
of longer fees. costs there professional adjusted that note to we as public company well an adjust and for been reconciliation EBITDA Please our unusual adjustment previously no XXXX and service has legal that as
was XXXX the XXXX our Interest third a $X.X the was compared the operations quarter in Orthex debt acquisition. last last The Vilex and was expense the increase period increase loss million continuing of in million $X.X of million period to $X.X in in the third in to related $X.X interest of loss to compared year. same year. Net related from in expense to million same quarter
$X.X net or basic of small share, $X.XX common was diluted net year. per per $X.XX attributable per share million the loss and in and operations period stockholders share $X.X basic diluted million loss, Total loss a same of compared a to from gain a to discontinued including or last
million Turning XXXX. to $X.X including the million to XXXX September $X.X deployed equipment consigned the compared as as million of million last Purchases of property million quarter the our $XX.X to of our $X $XX.X period of cash XX, quarter quarter compared XXXX, during June balance same the XX, during $X.X of during sheet, XXXX. were were third compared to balance third sets during million was implants of year, and
XXXX, sets period XXXX. We ended million track plans to This of $XX.X same $XX September now the million deployed XX% achieve $XX.X keeps a for of XX, have on year million compared deployment months X in us to total our set increase the is of $XX million. and XXXX to
associated million was $XX with million loan Vilex, As $XX.X of XXXX, debt total acquisition. the term Orthex XX, the September net including
As Mark a position line a our product debt in reduction by the adult advanced for expect mentioned, we of the outstanding finding and Vilex have significant buyer year-end. process
guidance, we revenue from annual to our growth XX%, to for of terms low XX%. In XX% of end XX% to the updated XXXX up
remain consigned our Additionally, million range XXXX. the on in and $XX $XX in between sets million deployed investment we track in with annual
Let me remarks. Mark now turn for the to call back over some closing
